These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9519805)

  • 21. Cerebral vasospasm and vasoconstriction caused by endothelin.
    Kobayashi H; Hayashi M; Kobayashi S; Kabuto M; Handa Y; Kawano H; Ide H
    Neurosurgery; 1991 May; 28(5):673-8; discussion 678-9. PubMed ID: 1876245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of endothelin-1 receptor antagonist BQ-123 on basilar artery diameter after subarachnoid hemorrhage (SAH) in rats.
    Jośko J; Hendryk S; Jedrzejowska-Szypułka H; Słowiński J; Gwóźdź B; Lange D; Harabin-Słowińska M
    J Physiol Pharmacol; 2000 Jun; 51(2):241-9. PubMed ID: 10898097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebrovascular characterization of clazosentan, the first nonpeptide endothelin receptor antagonist shown to be clinically effective for the treatment of cerebral vasospasm. Part II: effect on endothelin(B) receptor-mediated relaxation.
    Vatter H; Zimmermann M; Tesanovic V; Raabe A; Seifert V; Schilling L
    J Neurosurg; 2005 Jun; 102(6):1108-14. PubMed ID: 16028771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of endothelin antagonist BQ-610 on cerebral vascular wall following experimental subarachnoid hemorrhage and cerebral vasospasm.
    Cirak B; Kiymaz N; Ari HH; Ugras S
    Clin Auton Res; 2004 Jun; 14(3):197-201. PubMed ID: 15241650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prevention of cerebral vasospasms after experimental subarachnoid hemorrhage by the endothelin receptor antagonist RO 47-0203].
    Zimmermann M; Seifert V
    Zentralbl Neurochir; 1996; 57(3):143-9. PubMed ID: 8967274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelin and the production of cerebral vasospasm in dogs.
    Asano T; Ikegaki I; Suzuki Y; Satoh S; Shibuya M
    Biochem Biophys Res Commun; 1989 Mar; 159(3):1345-51. PubMed ID: 2649099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacology of A-216546: a highly selective antagonist for endothelin ET(A) receptor.
    Wu-Wong JR; Dixon DB; Chiou WJ; Dayton BD; Novosad EI; Adler AL; Wessale JL; Calzadilla SV; Hernandez L; Marsh KC; Liu G; Szczepankiewicz B; von Geldern TW; Opgenorth TJ
    Eur J Pharmacol; 1999 Feb; 366(2-3):189-201. PubMed ID: 10082200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endothelin ET(B1) receptor-mediated relaxation of rabbit basilar artery.
    Zuccarello M; Boccaletti R; Rapoport RM
    Eur J Pharmacol; 1998 Sep; 357(1):67-71. PubMed ID: 9788775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic administration of an inhibitor of endothelin-converting enzyme for attenuation of cerebral vasospasm following experimental subarachnoid hemorrhage.
    Caner HH; Kwan AL; Arthur A; Jeng AY; Lappe RW; Kassell NF; Lee KS
    J Neurosurg; 1996 Nov; 85(5):917-22. PubMed ID: 8893732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of an endothelin-1 antagonist, BQ-485, on cerebral oxygen metabolism after complete global cerebral ischemia in dogs.
    Takasu A; Matsushima S; Takino M; Okada Y
    Resuscitation; 1997 Feb; 34(1):65-9. PubMed ID: 9051826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cocaine-induced endothelin-1-dependent spasm in rabbit basilar artery in vivo.
    Fandino J; Sherman JD; Zuccarello M; Rapoport RM
    J Cardiovasc Pharmacol; 2003 Feb; 41(2):158-61. PubMed ID: 12548074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebrovascular selectivity and vasospasmolytic action of the novel calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]oxepin-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate in isolated cerebral arteries of the rabbit and dog.
    Minato H; Hashizume M; Masuda Y; Fujitani B; Hosoki K
    Arzneimittelforschung; 1997 Apr; 47(4):339-46. PubMed ID: 9150852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelin antagonists block alpha1-adrenergic constriction of coronary arterioles.
    DeFily DV; Nishikawa Y; Chilian WM
    Am J Physiol; 1999 Mar; 276(3):H1028-34. PubMed ID: 10070088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence endothelin ETA receptor antagonist--BQ-123--on changes of endothelin-1 level in plasma of rats with acute vasospasm following subarachnoid hemorrhage.
    Jośko J; Hendryk S; Jedrzejowska-Szypuła H; Gwóźdź B; Herman ZS; Gawlik R
    J Physiol Pharmacol; 1998 Sep; 49(3):367-75. PubMed ID: 9789790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional ET(A)-ET(B) Receptor Cross-talk in Basilar Artery In Situ From ET(B) Receptor Deficient Rats.
    Yoon S; Gariepy CE; Yanagisawa M; Zuccarello M; Rapoport RM
    J Cardiovasc Pharmacol; 2016 Mar; 67(3):212-7. PubMed ID: 26528589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of vasospasm after subarachnoid hemorrhage in dogs by continuous intravenous infusion of PD156707.
    Macdonald RL; Johns L; Lin G; Marton LS; Hallak H; Marcoux F; Kowalczuk A
    Neurol Med Chir (Tokyo); 1998; 38 Suppl():138-45. PubMed ID: 10234996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelin in cerebral vasospasm. Clinical and experimental results.
    Zimmermann M
    J Neurosurg Sci; 1997 Jun; 41(2):139-51. PubMed ID: 9385564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The peptide endothelin receptor antagonist, TAK-044, produces sustained inhibition of endothelin-1 mediated arteriolar vasoconstriction.
    Ferro CJ; Haynes WG; Johnston NR; Lomax CC; Newby DE; Webb DJ
    Br J Clin Pharmacol; 1997 Oct; 44(4):377-83. PubMed ID: 9354313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endothelin acts in feline and canine cerebral arteries from the adventitial side.
    Mima T; Yanagisawa M; Shigeno T; Saito A; Goto K; Takakura K; Masaki T
    Stroke; 1989 Nov; 20(11):1553-6. PubMed ID: 2683245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of endothelin-1 by the competitive ET(A) receptor antagonist Ro 61-1790 reduces lesion volume after cold injury in the rat.
    Görlach C; Hortobágyi T; Hortobágyi S; Benyó Z; Wahl M
    Pflugers Arch; 2001 Mar; 441(6):844-9. PubMed ID: 11316270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.